These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35434848)

  • 41. Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis.
    Jung CH; Rhee EJ; Kwon H; Chang Y; Ryu S; Lee WY
    Endocrinol Metab (Seoul); 2020 Mar; 35(1):165-176. PubMed ID: 32207277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
    Chen K; Sng WK; Quah JH; Liu J; Chong BY; Lee HK; Wang XF; Tan NC; Chang PE; Tan HC; Bee YM; Goh GBB
    PLoS One; 2020; 15(8):e0236977. PubMed ID: 32822391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
    Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
    JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Obesity and Weight Gain Are Associated With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Kim Y; Chang Y; Cho YK; Ahn J; Shin H; Ryu S
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):543-550.e2. PubMed ID: 30012432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study.
    Rotundo L; Persaud A; Feurdean M; Ahlawat S; Kim HS
    Clin Mol Hepatol; 2018 Dec; 24(4):392-401. PubMed ID: 30068065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statin use is not associated with presence of and severity of nonalcoholic fatty liver disease.
    Oni ET; Sinha P; Karim A; Martin SS; Blaha MJ; Agatston AS; Blumenthal RS; Meneghelo RS; Conceiçao RD; Santos RD; Nasir K
    Arch Med Res; 2014 Jan; 45(1):52-7. PubMed ID: 24333254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histological severity of nonalcoholic fatty liver disease is associated with 10-year risk for atherosclerotic cardiovascular disease.
    Park JH; Koo BK; Kim W; Kim WH;
    Hepatol Int; 2021 Oct; 15(5):1148-1159. PubMed ID: 34081289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD).
    D'Ambrosio R; Campi I; Maggioni M; Perbellini R; Giammona E; Stucchi R; Borghi M; Degasperi E; De Silvestri A; Persani L; Fugazzola L; Lampertico P
    PLoS One; 2021; 16(4):e0249614. PubMed ID: 33822817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease.
    Duseja A; Singh SP; Mehta M; Shalimar ; Venkataraman J; Mehta V; Devadas K; Kar SK; Goyal O; Nagral A; Saigal S; Nijhawan S; Praharaj D; Shukla A; Sharma B; Narayanasamy K; Kumar P; Rao PN; Arora A; Mehta R; Asati P; Ranjan P; Koshy A; Alam S; Mukewar S; Mukewar S; Mohan Prasad VG; Rastogi M; Sanyal AJ
    Metab Syndr Relat Disord; 2022 Apr; 20(3):166-173. PubMed ID: 35085026
    [No Abstract]   [Full Text] [Related]  

  • 50. In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis.
    Africa JA; Behling CA; Brunt EM; Zhang N; Luo Y; Wells A; Hou J; Belt PH; Kohil R; Lavine JE; Molleston JP; Newton KP; Whitington PF; Schwimmer JB;
    Clin Gastroenterol Hepatol; 2018 Mar; 16(3):438-446.e1. PubMed ID: 28286193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of serum vitamin C with liver fibrosis in adults with nonalcoholic fatty liver disease.
    Zhao Y; Li H
    Scand J Gastroenterol; 2022 Jul; 57(7):872-877. PubMed ID: 35189786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population-based follow-up study (NASHCO).
    Nabi O; Boursier J; Lapidus N; Mathurin P; de Ledinghen V; Petit JM; Goldberg M; Zins M; Lacombe K; Serfaty L
    Liver Int; 2022 Mar; 42(3):595-606. PubMed ID: 35066992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of non-alcoholic fatty liver disease with thyroid function: A systematic review and meta-analysis.
    Guo Z; Li M; Han B; Qi X
    Dig Liver Dis; 2018 Nov; 50(11):1153-1162. PubMed ID: 30224316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.
    Wijarnpreecha K; Thongprayoon C; Scribani M; Ungprasert P; Cheungpasitporn W
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):404-410. PubMed ID: 29215435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease.
    Fan H; Li L; Liu Z; Zhang P; Wu S; Han X; Chen X; Suo C; Cao L; Zhang T
    BMC Gastroenterol; 2023 Jan; 23(1):3. PubMed ID: 36604612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abdominal Obesity Phenotypes and Incidence of Thyroid Autoimmunity: A 9-Year Follow-up.
    Amouzegar A; Kazemian E; Abdi H; Gharibzadeh S; Tohidi M; Azizi F
    Endocr Res; 2020 Aug; 45(3):202-209. PubMed ID: 32266835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.
    Targher G; Valbusa F; Bonapace S; Bertolini L; Zenari L; Pichiri I; Mantovani A; Zoppini G; Bonora E; Barbieri E; Byrne CD
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):663-9. PubMed ID: 24594085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.
    Sun DQ; Liu WY; Wu SJ; Zhu GQ; Braddock M; Zhang DC; Shi KQ; Song D; Zheng MH
    Oncotarget; 2016 Feb; 7(5):5728-37. PubMed ID: 26735337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
    Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A
    BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.
    Hagström H; Nasr P; Ekstedt M; Kechagias S; Önnerhag K; Nilsson E; Rorsman F; Sheikhi R; Marschall HU; Hultcrantz R; Stål P
    Scand J Gastroenterol; 2017 Feb; 52(2):159-165. PubMed ID: 27650916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.